✦ LIBER ✦

PD-076 Phase II randomized trial of irinotecan/docetaxel oririnotecan/gemcitabine with or without celecoxib in 2nd-line treatment of non-small-cell lung cancer

✍ Scribed by Lilenbaum, R.; Socinski, M.; Altorki, N.; Hart, L.; Keresztes, R.; Hariharan, S.; Morrison, M.; Fayyad, R.; Bonomi, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-6 Phase II randomized trial of irinote

✍ Lilenbaum, Rogerio; Bonomi, Philip; Socinski, Mark Anthony 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Front-line treatment of advanced non-sma

✍ Georgoulias, V; Kourousis, Ch; Androulakis, N; Kakolyris, S; Dimopoulos, MA; Pap 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Docetaxel/gemcitabine or cisplatin/gemci

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

Docetaxel versus docetaxel plus gemcitab

✍ Georgoulias, Vassilis; Androulakis, Nikolaos; Kotsakis, Athanasios; Hatzidaki, D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 239 KB

A phase II randomized trial of gemcitabi

✍ Joaquín Casal Rubio; S. Vázquez; F. Vázquez; M. Amenedo; J. L. Fírvida; J. R. Me 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 255 KB

A Randomized Phase II Trial of Oral Topo

✍ Suzanne Jones; Dana Thompson; John Barton; Jeff Patton; Dianna Shipley; F. Antho 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 124 KB